Evidence map›Paper›PMID 32097412›Full record

ArticlePloS one2020

Investigating the ferric ion binding site of magnetite biomineralisation protein Mms6.

Andrea E Rawlings, Panah Liravi, Sybilla Corbett, Alex S Holehouse, Sarah S Staniland

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Cross-linking proteomics analysis for reliable identification of MamXY-associated magnetosome formation.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  2. Review
  3. Review
  4. The Magnetosome Protein, Mms6 fromInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Andrea E RawlingsDepartment of Chemistry, The University of Sheffield, Sheffield, England, United Kingdom.
Panah LiraviFaculty of Biological Sciences, The University of Leeds, Leeds, England, United Kingdom.
Sybilla CorbettFaculty of Biological Sciences, The University of Leeds, Leeds, England, United Kingdom.
Alex S HolehouseDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, United States of America.ORCID 0000-0002-4155-5729
Sarah S StanilandDepartment of Chemistry, The University of Sheffield, Sheffield, England, United Kingdom.ORCID 0000-0001-8995-7172
University of Leeds · GBUniversity of Sheffield · GBWashington University in St. Louis · US

Funding

Biotechnology and Biological Sciences Research Council BB/H005412/1Biotechnology and Biological Sciences Research Council BB/H005412/2
6 · The paper itself

Abstract

The biomineralization protein Mms6 has been shown to be a major player in the formation of magnetic nanoparticles both within the magnetosomes of magnetotactic bacteria and as an additive in synthetic magnetite precipitation assays. Previous studies have highlighted the ferric iron binding capability of the protein and this activity is thought to be crucial to its mineralizing properties. To understand how this protein binds ferric ions we have prepared a series of single amino acid substitutions within the C-terminal binding region of Mms6 and have used a ferric binding assay to probe the binding site at the level of individual residues which has pinpointed the key residues of E44, E50 and R55 involved in Mms6 ferric binding. No aspartic residues bound ferric ions. A nanoplasmonic sensing experiment was used to investigate the unstable EER44, 50,55AAA triple mutant in comparison to native Mms6. This suggests a difference in interaction with iron ions between the two and potential changes to the surface precipitation of iron oxide when the pH is increased. All-atom simulations suggest that disruptive mutations do not fundamentally alter the conformational preferences of the ferric binding region. Instead, disruption of these residues appears to impede a sequence-specific motif in the C-terminus critical to ferric ion binding.

Indexed as

BiomineralizationAmino Acid SequenceBacterial ProteinsBinding SitesFerrosoferric OxideIronMagnetospirillumMonte Carlo MethodMutationBacterial ProteinsFerrosoferric OxideIron

Identifiers

PMID32097412
PMCPMC7041794
OpenAlexW3006947961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.